Two technologies have been developed after an increase in accumulation of EGFR on the cell membrane was associated with improved EGFR inhibitor potency in squamous cell carcinomas (SCC).

UniQuest Contact: 

Maher Khaled

Position: 
Director, Commercial Engagement - Personalised Medicine
Mobile phone: 
+61 409 156 555
Work phone: 
+61 (7) 3365 4037